Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nilapanib Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113461597A reveals a cost-effective photoredox/Ni dual catalytic route for nilapanib intermediates, offering significant supply chain stability and reduced manufacturing costs.